Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T12:05:32.730Z.
Calculation as of: 2026-10-06T12:05:32.730Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: adca945f375d0863f0f013440b023eebfab0caffb47005764e85a23fe93f72ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-03-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
19.04x
EV/FCF RATIO AVG 3Y
19.04x
EV/FCF RATIO AVG 5Y
19.04x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aquestive Therapeutics, Inc.
Market Cap
$573.38M
EV/FCF Ratio
N/A
TTM Avg
19.04x
3Y Avg
19.04x
5Y Avg
19.04x
Market Cap
$579.88M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$561.67M
EV/FCF Ratio
N/A
TTM Avg
34.57x
3Y Avg
33.80x
5Y Avg
13.57x
Market Cap
$547.86M
EV/FCF Ratio
28.72x
TTM Avg
31.80x
3Y Avg
42.09x
5Y Avg
42.09x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $573.38M | N/A | 19.04x | 19.04x | 19.04x |
| CorMedix Inc. (CRMD)vs › | $569.56M | 1.83x | 8.01x | 10.23x | 10.23x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | N/A | 34.57x | 33.80x | 13.57x |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 28.72x | 31.80x | 42.09x | 42.09x |
| Altimmune, Inc. (ALT)vs › | $519.25M | N/A | 0.12x | 0.12x | 0.12x |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | N/A | 370.81x | 370.81x | 370.81x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-03-05 | 48.50x |
| 2024-03-04 | 48.39x |
| 2024-03-01 | 49.04x |
| 2024-02-29 | 42.89x |
| 2024-02-28 | 42.68x |
| 2024-02-27 | 37.83x |
| 2024-02-26 | 34.06x |
| 2024-02-23 | 31.04x |
| 2024-02-22 | 31.69x |
| 2024-02-21 | 30.40x |
| 2024-02-20 | 31.90x |
| 2024-02-16 | 32.44x |
| 2024-02-15 | 32.66x |
| 2024-02-14 | 32.23x |
| 2024-02-13 | 31.90x |
| 2024-02-12 | 33.20x |
| 2024-02-09 | 32.98x |
| 2024-02-08 | 32.23x |
| 2024-02-07 | 31.80x |
| 2024-02-06 | 33.41x |
| 2024-02-05 | 32.44x |
| 2024-02-02 | 31.69x |
| 2024-02-01 | 32.12x |
| 2024-01-31 | 29.10x |
| 2024-01-30 | 28.99x |
| 2024-01-29 | 29.86x |
| 2024-01-26 | 29.10x |
| 2024-01-25 | 28.89x |
| 2024-01-24 | 29.10x |
| 2024-01-23 | 30.29x |
| 2024-01-22 | 30.40x |
| 2024-01-19 | 29.64x |
| 2024-01-18 | 30.07x |
| 2024-01-17 | 31.69x |
| 2024-01-16 | 32.01x |
| 2024-01-12 | 31.69x |
| 2024-01-11 | 30.40x |
| 2024-01-10 | 30.93x |
| 2024-01-09 | 32.66x |
| 2024-01-08 | 30.29x |
| 2024-01-05 | 28.56x |
| 2024-01-04 | 27.70x |
| 2024-01-03 | 25.87x |
| 2024-01-02 | 25.01x |
| 2023-12-29 | 25.12x |
| 2023-12-28 | 24.90x |
| 2023-12-27 | 25.01x |
| 2023-12-26 | 24.90x |
| 2023-12-22 | 24.90x |
| 2023-12-21 | 23.82x |
| 2023-12-20 | 23.50x |
| 2023-12-19 | 24.58x |
| 2023-12-18 | 24.04x |
| 2023-12-15 | 24.90x |
| 2023-12-14 | 25.01x |
| 2023-12-13 | 25.76x |
| 2023-12-12 | 24.68x |
| 2023-12-11 | 24.58x |
| 2023-12-08 | 25.98x |
| 2023-12-07 | 26.52x |
| 2023-12-06 | 25.55x |
| 2023-12-05 | 29.10x |
| 2023-12-04 | 29.96x |
| 2023-12-01 | 29.10x |
| 2023-11-30 | 27.59x |
| 2023-11-29 | 26.84x |
| 2023-11-28 | 26.30x |
| 2023-11-27 | 24.25x |
| 2023-11-24 | 26.19x |
| 2023-11-22 | 25.33x |
| 2023-11-21 | 24.25x |
| 2023-11-20 | 22.64x |
| 2023-11-17 | 21.99x |
| 2023-11-16 | 21.88x |
| 2023-11-15 | 20.48x |
| 2023-11-14 | 20.81x |
| 2023-11-13 | 21.45x |
| 2023-11-10 | 21.45x |
| 2023-11-09 | 21.78x |
| 2023-11-08 | 21.34x |
| 2023-11-07 | 21.78x |
| 2023-11-06 | 12.11x |
| 2023-11-03 | 11.93x |
| 2023-11-02 | 10.97x |
| 2023-11-01 | 11.57x |
| 2023-10-31 | 11.75x |
| 2023-10-30 | 11.39x |
| 2023-10-27 | 10.85x |
| 2023-10-26 | 10.79x |
| 2023-10-25 | 10.73x |
| 2023-10-24 | 10.91x |
| 2023-10-23 | 10.79x |
| 2023-10-20 | 11.57x |
| 2023-10-19 | 11.99x |
| 2023-10-18 | 12.47x |
| 2023-10-17 | 12.95x |
| 2023-10-16 | 12.71x |
| 2023-10-13 | 11.57x |
| 2023-10-12 | 10.91x |
| 2023-10-11 | 10.53x |
| 2023-10-10 | 10.73x |
| 2023-10-09 | 10.26x |
| 2023-10-06 | 10.32x |
| 2023-10-05 | 10.11x |
| 2023-10-04 | 10.47x |
| 2023-10-03 | 10.67x |
| 2023-10-02 | 10.73x |
| 2023-09-29 | 11.51x |
| 2023-09-28 | 11.33x |
| 2023-09-27 | 11.45x |
| 2023-09-26 | 11.51x |
| 2023-09-25 | 11.33x |
| 2023-09-22 | 11.81x |
| 2023-09-21 | 12.11x |
| 2023-09-20 | 12.59x |
| 2023-09-19 | 11.51x |
| 2023-09-18 | 11.63x |
| 2023-09-15 | 12.05x |
| 2023-09-14 | 11.99x |
| 2023-09-13 | 12.29x |
| 2023-09-12 | 12.29x |
| 2023-09-11 | 11.75x |
| 2023-09-08 | 11.33x |
| 2023-09-07 | 11.81x |
| 2023-09-06 | 11.81x |
| 2023-09-05 | 12.23x |
| 2023-09-01 | 12.35x |
| 2023-08-31 | 12.17x |
| 2023-08-30 | 12.23x |
| 2023-08-29 | 12.53x |
| 2023-08-28 | 12.65x |
| 2023-08-25 | 13.07x |
| 2023-08-24 | 13.07x |
| 2023-08-23 | 13.07x |
| 2023-08-22 | 12.89x |
| 2023-08-21 | 12.95x |
| 2023-08-18 | 12.77x |
| 2023-08-17 | 12.77x |
| 2023-08-16 | 13.25x |
| 2023-08-15 | 13.42x |
| 2023-08-14 | 13.42x |
| 2023-08-11 | 13.96x |
| 2023-08-10 | 14.02x |
| 2023-08-09 | 14.38x |
| 2023-08-08 | 13.96x |
| 2023-08-07 | 15.59x |
| 2023-08-04 | 15.85x |
| 2023-08-03 | 16.45x |
| 2023-08-02 | 16.39x |
| 2023-08-01 | 16.85x |
| 2023-07-31 | 16.52x |
| 2023-07-28 | 14.72x |
| 2023-07-27 | 13.26x |
| 2023-07-26 | 13.26x |
| 2023-07-25 | 12.59x |
| 2023-07-24 | 12.26x |
| 2023-07-21 | 12.46x |
| 2023-07-20 | 12.59x |
| 2023-07-19 | 13.12x |
| 2023-07-18 | 12.86x |
| 2023-07-17 | 12.66x |
| 2023-07-14 | 12.33x |
| 2023-07-13 | 12.86x |
| 2023-07-12 | 12.73x |
| 2023-07-11 | 12.66x |
| 2023-07-10 | 12.93x |
| 2023-07-07 | 12.99x |
| 2023-07-06 | 13.26x |
| 2023-07-05 | 12.99x |
| 2023-07-03 | 12.66x |
| 2023-06-30 | 12.93x |
| 2023-06-29 | 12.53x |
| 2023-06-28 | 12.53x |
| 2023-06-27 | 12.99x |
| 2023-06-26 | 12.99x |
| 2023-06-23 | 14.12x |
| 2023-06-22 | 14.52x |
| 2023-06-21 | 15.39x |
| 2023-06-20 | 15.59x |
| 2023-06-16 | 16.32x |
| 2023-06-15 | 16.32x |
| 2023-06-14 | 16.65x |
| 2023-06-13 | 16.99x |
| 2023-06-12 | 15.79x |
| 2023-06-09 | 16.05x |
| 2023-06-08 | 16.25x |
| 2023-06-07 | 16.39x |
| 2023-06-06 | 16.85x |
| 2023-06-05 | 16.32x |
| 2023-06-02 | 16.99x |
| 2023-06-01 | 17.32x |
| 2023-05-31 | 17.32x |
| 2023-05-30 | 15.65x |
| 2023-05-26 | 16.85x |
| 2023-05-25 | 16.72x |
| 2023-05-24 | 17.12x |
| 2023-05-23 | 17.78x |
| 2023-05-22 | 17.98x |
| 2023-05-19 | 16.39x |
| 2023-05-18 | 15.32x |
| 2023-05-17 | 15.59x |
| 2023-05-16 | 15.92x |
| 2023-05-15 | 16.25x |
| 2023-05-12 | 15.06x |
| 2023-05-11 | 18.52x |
| 2023-05-10 | 18.18x |
| 2023-05-09 | 17.45x |
| 2023-05-08 | 16.92x |
| 2023-05-05 | 15.52x |
| 2023-05-04 | 14.99x |
| 2023-05-03 | 13.12x |
| 2018-11-06 | 56.37x |
| 2018-11-05 | 56.96x |
| 2018-11-02 | 55.72x |
| 2018-11-01 | 49.53x |
| 2018-10-31 | 49.21x |
| 2018-10-30 | 48.44x |
| 2018-10-29 | 47.67x |
| 2018-10-26 | 49.50x |
| 2018-10-25 | 48.23x |
| 2018-10-24 | 48.17x |
| 2018-10-23 | 48.05x |
| 2018-10-22 | 46.19x |
| 2018-10-19 | 46.93x |
| 2018-10-18 | 50.36x |
| 2018-10-17 | 51.54x |
| 2018-10-16 | 50.18x |
| 2018-10-15 | 49.09x |
| 2018-10-12 | 48.52x |
| 2018-10-11 | 45.98x |
| 2018-10-10 | 47.10x |
| 2018-10-09 | 48.23x |
| 2018-10-08 | 51.13x |
| 2018-10-05 | 52.20x |
| 2018-10-04 | 53.62x |
| 2018-10-03 | 57.26x |
| 2018-10-02 | 57.41x |
| 2018-10-01 | 55.66x |
| 2018-09-28 | 56.25x |
| 2018-09-27 | 55.66x |
| 2018-09-26 | 55.30x |
| 2018-09-25 | 56.22x |
| 2018-09-24 | 55.22x |
| 2018-09-21 | 52.76x |
| 2018-09-20 | 52.70x |
| 2018-09-19 | 52.91x |
| 2018-09-18 | 51.99x |
| 2018-09-17 | 53.35x |
| 2018-09-14 | 53.32x |
| 2018-09-13 | 58.62x |
| 2018-09-12 | 59.09x |
| 2018-09-11 | 58.53x |
| 2018-09-10 | 59.69x |
| 2018-09-07 | 60.54x |
| 2018-09-06 | 60.31x |
| 2018-09-05 | 57.58x |
| 2018-09-04 | 375.63x |
| 2018-08-31 | 377.96x |
| 2018-08-30 | 361.86x |
| 2018-08-29 | 356.43x |
Showing the most recent 260 of 285 data points. The chart above shows the full history.
